TheEdgeResearch
Home / Stocks / RSJN

FT Vest U.S. Equity Equal Weight Buffer ETF - June (RSJN)

AMEX Financial Services Asset Management
$37.36 ▲ +0.19%
Market Cap
$27.5M
Sector
Financial Services
Industry
Asset Management
Beta
0.47
52-Wk Range
33-38.35
CEO
—
Country
US
Currency
USD

FT Vest U.S. Equity Equal Weight Buffer ETF - June operates in the Asset Management industry of the Financial Services sector, headquartered in Wheaton, IL, US. The stock last traded at $37.36, up 0.19% on the session, giving a market capitalisation of $27.5M. Its beta of 0.47 implies it has historically moved less than the broad market.

Company profile
Exchange
New York Stock Exchange Arca
Employees
—
IPO date
2024-06-24
Headquarters
Wheaton, IL, US
About FT Vest U.S. Equity Equal Weight Buffer ETF - June

The FT Vest U.S. Equity Equal Weight Buffer ETF - June (referred to as the "Fund") is established with the primary aim of delivering investors returns that closely track the capital appreciation of the Invesco S&P 500 Equal Weight ETF Trust (its "Underlying ETF"). This tracking, however, comes with specific parameters: an upside potential limited to 15.79%, and a protective buffer designed to absorb the first 10% of any losses experienced by the Underlying ETF. These return characteristics and downside protection are applicable over a fixed period, commencing on June 23, 2025, and concluding on June 18, 2026, all calculated before the consideration of any fees and expenses. Typically, the Fund achieves its objectives by investing the vast majority of its capital in FLexible EXchange Options ("FLEX Options") that are linked to the price performance of the Invesco S&P 500 Equal Weight ETF Trust, assuming normal market circumstances.

Comparable companies

FT Vest U.S. Equity Equal Weight Buffer ETF - June is most often compared with the following Financial Services names:

AFALXCVLEXDIVELPREMGPIXPCIGRSSERWGFXRYUIXTGFRX
More research on RSJN
RSJN technical analysis RSJN TheEdge Score Compare against peers
Open full interactive analysis & DCF →